Skip to main content
. 2016 Jun 28;22(3):355–366. doi: 10.5056/jnm15150

Figure 5.

Figure 5

Control of heartburn over 24 hours by dexlansoprazole versus placebo in patients with healed erosive esophagitis (intent to treat population). *P < 0.0025 vs placebo. Adapted from Metz et al46 With permission from John Wiley & Sons, Inc. © 2009 Takeda Global Research & Development Center, Inc.